Gail K. Naughton
Overview
Gail K. Naughton received an average of $308K in total compensation, including $285K in salary, at Conatus Pharmaceuticals between 2019 and 2020.
Source: SEC filing on April 15, 2021.
Related executives
We found nine more executives who work or worked at Conatus Pharmaceuticals.
Susan Knudson
Conatus Pharmaceuticals
Chief Financial Officer
Steven Mento
Conatus Pharmaceuticals
Chief Executive Officer
Joyce Reyes
Conatus Pharmaceuticals
Senior Vice President of Regulatory, Quality, Clinical Operations & Technical Operations
Richard Pascoe
Conatus Pharmaceuticals
Chief Executive Officer
Keith Marshall
Conatus Pharmaceuticals
Chief Financial Officer
David Hagerty
Conatus Pharmaceuticals
Executive Vice President, Clinical Development
Alfred Spada
Conatus Pharmaceuticals
Chief Scientific Officer
Charles Cashion
Conatus Pharmaceuticals